Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers [NA]

View source ↗

Summary

A clinical trial led by ETH Zurich is evaluating breath markers to diagnose lactose intolerance and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ETH Zurich | Conditions: Lactose Intolerance | NA | Status: RECRUITING